Source:http://linkedlifedata.com/resource/pubmed/id/15305634
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2004-8-12
|
pubmed:abstractText |
Gastric banding is one of the most important measures in type II diabetes mellitus prevention and treatment. It decreases risk of diabetes development 32 times within 2 years and 5 times 8 years after the procedure. In diabetes treatment the gastric banding is the most effective measurement in morbidly obese diabetics. According to one study 82.9% of diabetics and 98.7% of patients with impaired glucose tolerance had 14 years after gastric banding normal levels of blood sugar and glycosylated hemoglobin. Our experience also shows an important effect of gastric banding on diabetes although weight loss is lower compared to nondiabetics. This important treatment option is still passed by our diabetologists. Gastric banding is not indicated for type I diabetes.
|
pubmed:language |
cze
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0042-773X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
371-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
2004
|
pubmed:articleTitle |
[Gastric banding and diabetes mellitus].
|
pubmed:affiliation |
III. interní klinika 1. lékarské fakulty UK a VFN, Praha.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|